[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Biologics and Biosimilars Market Report 2016

October 2016 | 121 pages | ID: E70F10326C3EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Biologics and Biosimilars

Revenue, means the sales value of Biologics and Biosimilars

This report studies sales (consumption) of Biologics and Biosimilars in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Pfizer
  • Roche
  • Amgen
  • AbbVie
  • Sanofi
  • Johnson & Johnson
  • Novo Nordisk
  • Novartis
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biologics and Biosimilars in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Biologics
  • Biosimilars
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Biologics and Biosimilars in each application, can be divided into
  • Tumor
  • Diabetes
  • Cardiovascular
  • Others
Europe Biologics and Biosimilars Market Report 2016

1 BIOLOGICS AND BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
  1.2.1 Biologics
  1.2.2 Biosimilars
  1.2.3 Type III
1.3 Application of Biologics and Biosimilars
  1.3.1 Tumor
  1.3.2 Diabetes
  1.3.3 Cardiovascular
  1.3.4 Others
1.4 Biologics and Biosimilars Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Biologics and Biosimilars (2011-2021)
  1.5.1 Europe Biologics and Biosimilars Sales and Growth Rate (2011-2021)
  1.5.2 Europe Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

2 EUROPE BIOLOGICS AND BIOSIMILARS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Biologics and Biosimilars Market Competition by Manufacturers
  2.1.1 Europe Biologics and Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Biologics and Biosimilars (Volume and Value) by Type
  2.2.1 Europe Biologics and Biosimilars Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
2.3 Europe Biologics and Biosimilars (Volume and Value) by Countries
  2.3.1 Europe Biologics and Biosimilars Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Biologics and Biosimilars Revenue and Market Share by Countries (2011-2016)
2.4 Europe Biologics and Biosimilars (Volume) by Application

3 GERMANY BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Biologics and Biosimilars Sales and Value (2011-2016)
  3.1.1 Germany Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  3.1.2 Germany Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Biologics and Biosimilars Sales Price Trend (2011-2016)
3.2 Germany Biologics and Biosimilars Sales and Market Share by Manufacturers
3.3 Germany Biologics and Biosimilars Sales and Market Share by Type
3.4 Germany Biologics and Biosimilars Sales and Market Share by Application

4 FRANCE BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 France Biologics and Biosimilars Sales and Value (2011-2016)
  4.1.1 France Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  4.1.2 France Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  4.1.4 France Biologics and Biosimilars Sales Price Trend (2011-2016)
4.2 France Biologics and Biosimilars Sales and Market Share by Manufacturers
4.3 France Biologics and Biosimilars Sales and Market Share by Type
4.4 France Biologics and Biosimilars Sales and Market Share by Application

5 UK BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Biologics and Biosimilars Sales and Value (2011-2016)
  5.1.1 UK Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  5.1.2 UK Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  5.1.5 UK Biologics and Biosimilars Sales Price Trend (2011-2016)
5.2 UK Biologics and Biosimilars Sales and Market Share by Manufacturers
5.3 UK Biologics and Biosimilars Sales and Market Share by Type
5.4 UK Biologics and Biosimilars Sales and Market Share by Application

6 RUSSIA BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Biologics and Biosimilars Sales and Value (2011-2016)
  6.1.1 Russia Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  6.1.2 Russia Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Biologics and Biosimilars Sales Price Trend (2011-2016)
6.2 Russia Biologics and Biosimilars Sales and Market Share by Manufacturers
6.3 Russia Biologics and Biosimilars Sales and Market Share by Type
6.4 Russia Biologics and Biosimilars Sales and Market Share by Application

7 ITALY BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Biologics and Biosimilars Sales and Value (2011-2016)
  7.1.1 Italy Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  7.1.2 Italy Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Biologics and Biosimilars Sales Price Trend (2011-2016)
7.2 Italy Biologics and Biosimilars Sales and Market Share by Manufacturers
7.3 Italy Biologics and Biosimilars Sales and Market Share by Type
7.4 Italy Biologics and Biosimilars Sales and Market Share by Application

8 SPAIN BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Biologics and Biosimilars Sales and Value (2011-2016)
  8.1.1 Spain Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  8.1.2 Spain Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Biologics and Biosimilars Sales Price Trend (2011-2016)
8.2 Spain Biologics and Biosimilars Sales and Market Share by Manufacturers
8.3 Spain Biologics and Biosimilars Sales and Market Share by Type
8.4 Spain Biologics and Biosimilars Sales and Market Share by Application

9 BENELUX BIOLOGICS AND BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Biologics and Biosimilars Sales and Value (2011-2016)
  9.1.1 Benelux Biologics and Biosimilars Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Biologics and Biosimilars Sales Price Trend (2011-2016)
9.2 Benelux Biologics and Biosimilars Sales and Market Share by Manufacturers
9.3 Benelux Biologics and Biosimilars Sales and Market Share by Type
9.4 Benelux Biologics and Biosimilars Sales and Market Share by Application

10 EUROPE BIOLOGICS AND BIOSIMILARS MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Biologics and Biosimilars Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Roche
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Biologics and Biosimilars Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Amgen
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Biologics and Biosimilars Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 AbbVie
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Biologics and Biosimilars Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Sanofi
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Biologics and Biosimilars Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Johnson & Johnson
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Biologics and Biosimilars Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Novo Nordisk
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Biologics and Biosimilars Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Novartis
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Biologics and Biosimilars Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview

11 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS

11.1 Biologics and Biosimilars Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biologics and Biosimilars

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Biologics and Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2016-2021)

14.1 Germany Biologics and Biosimilars Sales Forecast (2016-2021)
14.2 France Biologics and Biosimilars Sales Forecast (2016-2021)
14.3 UK Biologics and Biosimilars Sales Forecast (2016-2021)
14.4 Russia Biologics and Biosimilars Sales Forecast (2016-2021)
14.5 Italy Biologics and Biosimilars Sales Forecast (2016-2021)
14.6 Spain Biologics and Biosimilars Sales Forecast (2016-2021)
14.7 Benelux Biologics and Biosimilars Sales Forecast (2016-2021)
14.8 Europe Biologics and Biosimilars Sales Forecast by Type (2016-2021)
14.9 Europe Biologics and Biosimilars Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure Europe Sales Market Share of Biologics and Biosimilars by Type in 2015
Figure Biologics Picture
Figure Biosimilars Picture
Table Application of Biologics and Biosimilars
Figure Europe Sales Market Share of Biologics and Biosimilars by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Others Examples
Figure Germany Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure France Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure UK Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Spain Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Benelux Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Biologics and Biosimilars Sales and Growth Rate (2011-2021)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2011-2021)
Table Europe Biologics and Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Europe Biologics and Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Sales Share by Manufacturers
Figure 2016 Biologics and Biosimilars Sales Share by Manufacturers
Table Europe Biologics and Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Europe Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 Europe Biologics and Biosimilars Revenue Share by Manufacturers
Table Europe Biologics and Biosimilars Sales and Market Share by Type (2011-2016)
Table Europe Biologics and Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Biologics and Biosimilars by Type (2011-2016)
Figure Europe Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)
Table Europe Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)
Table Europe Biologics and Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2011-2016)
Figure Europe Biologics and Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Europe Biologics and Biosimilars Sales and Market Share by Countries (2011-2016)
Table Europe Biologics and Biosimilars Sales Share by Countries (2011-2016)
Figure Sales Market Share of Biologics and Biosimilars by Countries (2011-2016)
Table Europe Biologics and Biosimilars Revenue and Market Share by Countries (2011-2016)
Table Europe Biologics and Biosimilars Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Biologics and Biosimilars by Countries (2011-2016)
Table Europe Biologics and Biosimilars Sales and Market Share by Application (2011-2016)
Table Europe Biologics and Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Biologics and Biosimilars by Application (2011-2016)
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure Germany Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure Germany Biologics and Biosimilars Sales Price Trend (2011-2016)
Table Germany Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Germany Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Germany Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Germany Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Germany Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Germany Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure France Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure France Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure France Biologics and Biosimilars Sales Price Trend (2011-2016)
Table France Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table France Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table France Biologics and Biosimilars Sales by Type (2015 and 2016)
Table France Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table France Biologics and Biosimilars Sales by Application (2015 and 2016)
Table France Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure UK Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure UK Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure UK Biologics and Biosimilars Sales Price Trend (2011-2016)
Table UK Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table UK Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table UK Biologics and Biosimilars Sales by Type (2015 and 2016)
Table UK Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table UK Biologics and Biosimilars Sales by Application (2015 and 2016)
Table UK Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure Russia Biologics and Biosimilars Sales Price Trend (2011-2016)
Table Russia Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Russia Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Russia Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Russia Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Russia Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Russia Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure Italy Biologics and Biosimilars Sales Price Trend (2011-2016)
Table Italy Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Italy Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Italy Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Italy Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Italy Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Italy Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure Spain Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure Spain Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure Spain Biologics and Biosimilars Sales Price Trend (2011-2016)
Table Spain Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Spain Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Spain Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Spain Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Spain Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Spain Biologics and Biosimilars Market Share by Application (2015 and 2016)
Figure Benelux Biologics and Biosimilars Sales and Growth Rate (2011-2016)
Figure Benelux Biologics and Biosimilars Revenue and Growth Rate (2011-2016)
Figure Benelux Biologics and Biosimilars Sales Price Trend (2011-2016)
Table Benelux Biologics and Biosimilars Sales by Manufacturers (2015 and 2016)
Table Benelux Biologics and Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Benelux Biologics and Biosimilars Sales by Type (2015 and 2016)
Table Benelux Biologics and Biosimilars Market Share by Type (2015 and 2016)
Table Benelux Biologics and Biosimilars Sales by Application (2015 and 2016)
Table Benelux Biologics and Biosimilars Market Share by Application (2015 and 2016)
Table Biologics and Biosimilars Basic Information List
Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Biologics and Biosimilars Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Biologics and Biosimilars Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biologics and Biosimilars Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Biologics and Biosimilars Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Biologics and Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Biologics and Biosimilars Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Biologics and Biosimilars Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Biologics and Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Germany Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Germany Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure France Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure France Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure UK Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure UK Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Russia Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Italy Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Spain Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Europe Biologics and Biosimilars Sales Forecast by Type (2016-2021)
Table Europe Biologics and Biosimilars Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories